Overview

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This is a single ascending dose study to assess the safety, tolerability and pharmacokinetics of AZD4451.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca